The Effect Of Buddhist Care Program On Health-Related Quality Of Life In Patients With Advanced Cholangiocarcinoma.
Article Sidebar
Main Article Content
Abstract
Purpose: to compare the effect of Buddhist care program on Health-related Quality of life (HRQOL) in patients with advanced cholangiocarcinoma (CCA) before and after finished receiving the program at the hospital, and at home and 6th week in the follow up period.
Design: This study was a Quasi experimental with single-group time-series design;4 times measurement at different time points
Methods: The samples were 24 advanced cholangiocarcinoma patients who were Buddhist, age 20 years old and over. The instruments were Demographic data record form, the Buddhist care program, the Functional Assessment of Chronic Illness Therapy-Palliative Care (FACIT-Pal) in Thai version, and the Buddhist Death Acceptance scale, the Cronbach alpha coefficient of the last two instrument were 0.94 and 0.73, respectively. The participants received usual nursing care and Buddhist care program in hospital and take it to practice at home. Data were analyzed using repeated measure one-way analysis of variance (One-way repeated ANOVA)
Result: The mean scores of overall HRQOL in advanced cholangiocarcinoma patients after receiving the program at the hospital and at home were significantly higher than before receiving the program (p< .05). But there was no difference mean scores of overall HRQOL between the 6th week follow-up period and before receiving the program. However, mean scores of the emotional well-being dimension after receiving the program in the follow up period at 6th week was significantly higher than that of before receiving the program (p< .05).
Conclusion: The Buddhist care program can improve HRQOL in advanced cholangiocarcinoma patients after finished receiving the program at the hospital and at home. Moreover, the program’s outcome can continue to enhance the emotional well-being of patients in the follow up period.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ลิขสิทธิ์ของบทความที่ตีพิมพ์เป็นของวารสารพยาบาลศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย ทั้งฉบับตีพิมพ์เป็นรูปเล่มและเอกสารออนไลน์
References
Banales JM, Marin JJ, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–88.
Kamsa-ard S, Kamsa-ard S, Luvira V, Suwanrungruang K, Vatanasapt P, Wiangnon S. Risk factors for cholangiocarcinoma in Thailand: a systematic review and meta-analysis. Asian Pac J Cancer Prev APJCP. 2018;19(3):605.
Blechacz B. Cholangiocarcinoma: current knowledge and new developments. Gut Liver. 2017;11(1):13.
Cella DF. Quality of life: concepts and definition. J Pain Symptom Manage. 1994;9(3):186–92.
Mihalache F, Tantau M, Diaconu B, Acalovschi M. Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period. J Gastrointestin Liver Dis. 2010;19(3).
Woradet S, Songserm N, Promthet S, Parkin DM. Health-related quality of life and survival of cholangiocarcinoma patients in northeastern region of Thailand. PLoS One. 2016;11(9):e0163448.
Zabernigg A, Giesinger JM, Pall G, Gamper EM, Gattringer K, Wintner LM, et al. Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract. BMC Cancer. 2012;12(1):1–8.
Bibeau K, Bachini M, Lindley A, Barkey NM, Lindsey S. Exploring the diagnostic journey and life impact of patients with cholangiocarcinoma (CCA): Results from a large patient survey in the United States. 2021;
Siani E. Fields of Life and Death: Cholangiocarcinoma, Food Consumption, and Masculinity in Buddhist Rural Thailand. 2022;
Somjaivong B, Thanasilp S, Preechawong S, Sloan R. The influence of symptoms, social support, uncertainty, and coping on health-related quality of life among cholangiocarcinoma patients in northeast Thailand. Cancer Nurs. 2011;34(6):434–42.
World Health Organization. Strengthening of palliative care as a component of integrated treatment throughout the life course. J Pain Palliat Care Pharmacother. 2014;28(2):130–4.
Pattarapong Thammarongpreechachai. Wisdom of Happiness through Self-Compassion. J Lib Arts Maejo Univ. 2021;9(2):224–37.
Krapo M, Thanasilp S, Chimluang J. Factors Associated With Death Acceptance Among Thai Patients With Advanced Cancer1. Asian J Public Opin Res. 2018;6(1):18–30.
Ray A, Block SD, Friedlander RJ, Zhang B, Maciejewski PK, Prigerson HG. Peaceful awareness in patients with advanced cancer. J Palliat Med. 2006;9(6):1359–68.
Philipp R, Mehnert A, Lo C, Müller V, Reck M, Vehling S. Characterizing death acceptance among patients with cancer. Psycho‐Oncology. 2019;28(4):854–62.
Lin CP, Evans CJ, Koffman J, Sheu SJ, Hsu SH, Harding R. What influences patients’ decisions regarding palliative care in advance care planning discussions? Perspectives from a qualitative study conducted with advanced cancer patients, families and healthcare professionals. Palliat Med. 2019;33(10):1299–309.
Forner A, Vidili G, Rengo M, Bujanda L, Ponz‐Sarvisé M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019; 39:98–107.
Cohen J. Statistical power analysis for the behavioural sciences, xxi. Hillsdale NJ Erlbaum Assoc. 1998;
Thanasilp S, Akkayagorn L, Suwannapong K, Long NH, Chimluang J, Upasen R, et al. The Development and Psychometric Testing of the Buddhist Death Acceptance Scale. Pac Rim Int J Nurs Res. 2020;24(4):527–37.
Chinda M, Jaturapatporn D, Kirshen AJ, Udomsubpayakul U. Reliability and validity of a thai version of the edmonton symptom assessment system (ESAS–Thai). BMJ Support Palliat Care. 2012;2(Suppl 1):A8–9.
Soowit B, Panasakulkan S, Muksiritipanun B. The assessment of the suffering symptoms in palliative care patients. Songklanagarind J Nurs. 2015;35(1):153–64.
Phra Sakdithat Samvaro. The Model and Process of Caring for the End-of-Life Patients according to the Buddhist Principles of People in Phrae Province. Dhammathas Acad J. 2019;19(2):175–88.